| Typicality: | 0.404 |
| Saliency: | 0.361 |
| for abuse | 44 | purpose |
| in schedule iii | 8 | temporal |
| according to the csa | 6 | other |
| drug → have → low potential | 42 |
| drug → have → moderate to low potential | 3 |
| negative | neutral | positive |
| 0.431 | 0.471 | 0.098 |
| Raw frequency | 45 |
| Normalized frequency | 0.361 |
| Modifier score | 0.500 |
| Perplexity | 163.923 |